Rethinking post-operative delirium in cancer survivors: the role of delayed cord clamping
Published
January 30, 2025
Paper ID
PAP-000058
Status
Published
DOI
10.65712/tmj.test000316
Advance Services
Abstract
Background: Earlier studies of delayed cord clamping were small or single-centre. Methods: We conducted a prospective cohort study across 3 centres between 2019 and 2024. Results: 3178 participants were included (median age 54 years). Effects were consistent across prespecified subgroups. Conclusion: Implementation will depend on staffing, cost and local protocols.
Introduction
Practice around delayed cord clamping varies widely between centres. The cost of post-operative delirium to health systems is substantial. post-operative delirium remains a leading cause of avoidable harm among cancer survivors.
The cost of post-operative delirium to health systems is substantial. Earlier studies of delayed cord clamping were small or single-centre. post-operative delirium remains a leading cause of avoidable harm among cancer survivors.
Discussion
Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment.
Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment. Future work should test delayed cord clamping in a pragmatic multicentre trial.
These findings suggest that delayed cord clamping is associated with better post-operative delirium in cancer survivors. Strengths include the sample size and blinded outcome assessment. Future work should test delayed cord clamping in a pragmatic multicentre trial. Residual confounding cannot be excluded.
Conclusions
Delayed cord clamping may be offered for cancer survivors to improve post-operative delirium.
References
1. Larsen T, Volkov T, et al. Delayed cord clamping and health-related quality of life. Diabetes Care. 2019;379(4):8-1651.
2. Tanaka G, Silva L, et al. Tranexamic acid and medication adherence. Pediatrics. 2021;58(4):85-1398.
3. Herrera X, Patel Q, et al. Low-dose aspirin and time to diagnosis. BMC Med. 2021;90(11):734-1663.
4. Ahmed Y, Haddad C, et al. Machine-learning triage and in-hospital mortality. BMC Med. 2021;180(2):159-1249.
5. Lindqvist Y, Schmidt P, et al. Tranexamic acid and time to diagnosis. Eur Heart J. 2025;184(6):761-1079.
6. Novak N, Yilmaz I, et al. Delayed cord clamping and 30-day readmission. N Engl J Med. 2025;263(11):829-1582.
7. Nasser S, Volkov R, et al. An enhanced recovery pathway and in-hospital mortality. Eur Heart J. 2013;170(6):807-1774.
8. Ahmed B, Mueller W, et al. Home-based cardiac rehabilitation and acute kidney injury. Pediatrics. 2018;99(1):146-1419.
9. Rossi C, Kim P, et al. A sepsis alert system and acute kidney injury. Eur Heart J. 2015;49(3):670-1663.
10. Andersen W, Farouk W, et al. Continuous glucose monitoring and medication adherence. Ann Intern Med. 2015;151(10):297-1082.
Appendices
The statistical analysis plan is in the online supplement.
Materials and Methods
Eligible participants were cancer survivors. Analyses were adjusted for age, sex and baseline severity.
Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation. Eligible participants were cancer survivors.
Missing data were handled with multiple imputation. The primary outcome was post-operative delirium, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.
Results
Effects were consistent across prespecified subgroups. post-operative delirium occurred in 22% of the intervention group versus 28% of controls.
The adjusted odds ratio was 0.53 (95% CI 0.37 to 0.85). The adjusted odds ratio was 0.38 (95% CI 0.33 to 0.60).
The adjusted odds ratio was 0.41 (95% CI 0.37 to 0.78). The adjusted odds ratio was 0.73 (95% CI 0.34 to 0.84). Serious adverse events were rare and similar between groups.
| Group | n | Events |
|---|---|---|
| Female | 307 | 106 |
| Control | 684 | 106 |
| Control | 505 | 114 |
| Age ≥ 65 | 92 | 104 |
| Age < 65 | 664 | 82 |
| Male | 566 | 62 |
| Centre A | 795 | 72 |
Values are n (%) unless stated otherwise.

Shown for cancer survivors; error bars are 95% confidence intervals.
Effects were consistent across prespecified subgroups. post-operative delirium occurred in 17% of the intervention group versus 12% of controls.
Serious adverse events were rare and similar between groups. post-operative delirium occurred in 16% of the intervention group versus 13% of controls. Effects were consistent across prespecified subgroups.